Rare diseases
Investigational molecules
Locations
Back to Spain371 clinical trials in Palma, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
SpainStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
SpainStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
SpainStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SpainStudy on Balcinrenone and Dapagliflozin for Adults with Chronic Kidney Disease and Albuminuria
SpainStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
SpainStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
SpainStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
SpainStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
SpainStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SpainStudy of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
SpainStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
SpainThe busiest research cities in the country
What the registry says about research in the country
The cancer research activity in Palma De Mallorca focuses on improving treatment options for multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, myelodysplastic syndrome, and advanced non-small cell lung cancer. These studies are designed to assess whether newer therapies can improve disease control and patient outcomes.
Across these trials, researchers are comparing innovative approaches with existing care to better understand how to extend survival and deepen responses.
Clinical trial work in cardiovascular diseases is centered on primary prevention of atherosclerotic cardiovascular disease. The main goal is to see whether new preventive strategies can lower the risk of serious heart and vascular events in people at elevated risk.
These studies aim to strengthen early prevention and support better long-term cardiovascular health.
This research area includes studies in hematologic cancers such as multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, and myelodysplastic syndrome. The focus is on testing therapies that may improve control of blood-related malignancies and deepen treatment responses.
Investigators are working to refine treatment strategies for patients with difficult-to-treat hematologic conditions.
Trials in nervous system diseases are exploring better ways to prevent and ease chronic postsurgical pain after inguinal hernia repair. The aim is to reduce the chance that short-term surgical pain becomes a lasting problem.
These studies focus on making recovery more comfortable and helping patients return to normal activity more smoothly.
Research in stomatognathic diseases is examining ways to prevent clinically relevant oral bleeding after tooth extraction in patients using direct oral anticoagulants or vitamin K antagonists. The purpose is to improve safety in everyday dental care for people on blood-thinning treatment.
These studies aim to support safer dental procedures without compromising cardiovascular protection.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
